3-Praziquantel-4-(4-chlorophenylsulfonyl)-1,2,5-oxadiazol-2-oxide was synthesized via the coupling reaction of praziquante and 1,2,5-oxadiazole in ethylene glycol, and its molecular structure was confirmed by the melting point and spectroscopic data (UV, IR, and 1 H NMR). Moreover, it may be a potential anti-schistosmal agent.
Synthesis of 3-praziquantel-4-(4-chlorophenylsulfonyl)-1,2,5-oxadiazol-2-oxide
4-(4-chlorophenylsulfonyl)-3-(2-hydroxyethoxy)-1,2,5-oxadiazole-2-oxide (0.641 g, 2 mmol) was dissolved in CH 2 Cl 2 (50 mL), and praziquante (0.686 g, 2.2 mmol) was added, followed by addition of fuming sulfuric acid (98%, 15 mL). Under acidic condition, even on the position of praziquante on the occurrence of benzene Fourier alkylation reaction occurred and the target product 3-praziquantel-4-(4-chlorophenylsulfonyl)-1,2,5-oxadiazol-2-oxide was afforded. Yield: 25%, mp: Physical Measurements 1 H NMR spectrum was recorded on Bruker Avance III (400 MHz) spectrometer with SiMe 4 as the internal reference in CD 3 OD. UV absorption spectrum in CH 2 Cl 2 was measured on a Shimadzu cintra10 spectrometer. The melting points was performed on a WHF203B micro melting point apparatus. Fourier transform infrared (FT-IR) spectra was collected on a AVATAR 360 FT-IR spectrometer (Australia GBC Scientific Instrument) using KBr pellet.
Results and Discussion
The target product 3-praziquantel-4-(4-chlorophenylsulfonyl)-1,2,5-oxadiazol-2-oxide has been successfully synthesized (Scheme 1). It is a white flocky crystalline solid, and it is soluble in ethyl acetate and sparingly soluble in methanol. In its UV spectrum (Figure 1 ), there are two main absorption bands maximized at 224 nm and 252 nm, respectively. In the infrared spectrum, its characteristic v(C=O) peak appears at 1745 cm -1 . All the proton signals can be observed in its 1 H NMR spectrum (Figure 2 ). 
Conclusion
3-Praziquantel-4-(4-chlorophenylsulfonyl)-1,2,5-oxadiazol-2-oxide has been successfully synthesized by the coupling reaction between 3,4-bis(phenylsulfonyl)-1,2,5-oxadiazole-2-oxide and praziquante in ethylene glycol. Its molecular structure has been characterized by the melting point and spectroscopic data (UV, IR, and 1 H NMR), and it may be a potential anti-schistosmal agent.
